cover image: Executive Summary Methamphetamine Sample Characteristics Cocaine Heroin Cannabis and/or Cannabinoid-related

20.500.12592/q2bvw0c

Executive Summary Methamphetamine Sample Characteristics Cocaine Heroin Cannabis and/or Cannabinoid-related

30 Nov 2023

Perceived purity of crystal Coast, Queensland (QLD) in 2023 (N=103) was methamphetamine remained stable between consistent with the Brisbane/Gold Coast profile 2022 and 2023, with 28% of participants in previous years, whereby almost two thirds perceiving crystal methamphetamine as being (66%) were male, with a median age of 45 ‘low’ in purity in 2023 (19% in 2022, p=0.565). [...] There was also a significant decrease in any o In 2023, few participants (n≤5) reported recent use of codeine (n≤5; 17% in 2022, receptive or distributive sharing of a p=0.006), as well as a significant decrease in needle or syringe in the past month, recent non-prescribed use of codeine (n≤5; respectively. [...] (83%; 86% in 2022) and e-cigarettes (34%; 27% o The median opioid SDS score was six in 2022) remained stable in 2023, while (IQR=0–14), indicating many significantly fewer participants reported daily participants reported symptoms of use of alcohol (n≤5; 15% in 2022; p=0.006). [...] 2 Illicit Drug Reporting System 2023 o Almost two fifths (38%) of the sample o Thirty-three per cent of participants reported that they had received a reported engaging in ‘any’ crime in the hepatitis C virus (HCV) antibody test in past month in 2023, stable from 41% in the past year and 32% reported 2022, with 26% having been arrested in receiving an RNA test in the past year. [...] o The majority (94%) of participants reported accessing any health service for alcohol and/or drug support in the six months preceding interview, and 10% of the sample reported experiencing stigma in specialist AOD service setting in the six months preceding interview, a significant decrease from 2022 (20%; p=0.050).

Authors

Toni Karlsson

Pages
3
Published in
Australia